Latest news

Clinical

Axiom Reports Phase 1 Results for Stem Cell Therapy in Newborn Brain Injuries

Axiom Biosciences has reported results from a phase 1 clinical trial evaluating an umbilical cord-derived mesenchymal stem cell (MSC)...
Commercial

AstraZeneca travels to China once more and purchases Dizal’s lung cancer medication for up to $1.5 billion

AstraZeneca has committed to spending up to $1.5 billion to partner with Dizal Pharmaceutical of China for an exclusive,...
Commercial

Spero Shells Out Over $1B For Innovent’s Autoimmune Antibody

Spero Therapeutics is reshaping its strategy by shifting its focus from antibiotics to immune and inflammatory diseases through a...
Research & Development

Biogen’s Phase 2 Diranersen Data Shows Reduced Cognitive Decline in Alzheimer’s Disease

Biogen has presented phase 2 results for diranersen, an investigational tau-targeting treatment for Alzheimer’s disease, reporting reductions in cognitive...
Clinical

Sac-TMT and Keytruda Improve Progression-Free Survival in PD-L1-Negative NSCLC

Kelun-Biotech and Merck & Co.’s antibody-drug conjugate sacituzumab tirumotecan...
Insights

The Future of Smart Biopharmaceutical Manufacturing

Executive Summary Biopharmaceutical manufacturing is entering a period of profound...
Insights

Top 10 Risks Pharma Leaders Underestimate in AI Deployment

Pharma Leaders:Executive Summary Artificial intelligence is rapidly becoming a strategic priority across the pharmaceutical industry. Organizations are investing heavily in...
Clinical

Veradermics Reports Phase 2 Results for VDPHL01 in Women With Pattern Hair Loss

Veradermics has reported topline results from an open-label Phase 2 study evaluating VDPHL01, an extended-release oral formulation of minoxidil,...
Clinical

Dysport Meets Phase 3 Goals in Episodic and Chronic Migraine Trials

Ipsen announced that its neurotoxin Dysport achieved the primary goals in two Phase 3 clinical trials evaluating the treatment...
Clinical

J&J Reports Positive Phase 2/3 Results for Imaavy in Warm Autoimmune Hemolytic Anemia

Johnson & Johnson has reported results from the pivotal...
Manufacturing

Edgewise Reports Phase 2 CIRRUS-HCM Results for EDG-7500 Ahead of Planned Phase 3 Development

Edgewise Therapeutics has reported top-line results from Part D...
Research & Development

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

The Advanced Research Projects Agency for Health (ARPA-H) has announced a new round of funding through its THRIVE program,...
Clinical

Bausch + Lomb Ends BL1107 Glaucoma Program After Phase 2 Trial Misses Main Goal

Bausch + Lomb has decided to discontinue development of its investigational glaucoma eye drop BL1107 after the treatment failed...
Insights

Top 10 Barriers to Scaling Genomics Programs in Healthcare

Executive Summary Genomics is rapidly becoming a cornerstone of modern healthcare. Advances in next-generation sequencing (NGS), precision medicine, artificial intelligence...
Commercial

AstraZeneca sells assets and signs gene therapy agreement with Pfizer

AstraZeneca is undergoing significant transformations, as evidenced by a...
Commercial

Gilead Explores Triple-Target T-Cell Engagers in over $1.5B Merus Partnership

Bispecific T-cell engagers are gaining prominence in oncology, yet...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

Regulatory

Commercial

AstraZeneca travels to China once more and purchases Dizal’s lung cancer medication for up to $1.5 billion

AstraZeneca has committed to spending up to $1.5 billion...
Commercial

Spero Shells Out Over $1B For Innovent’s Autoimmune Antibody

Spero Therapeutics is reshaping its strategy by shifting its...
Research & Development

Biogen’s Phase 2 Diranersen Data Shows Reduced Cognitive Decline in Alzheimer’s Disease

Biogen has presented phase 2 results for diranersen, an...
Commercial

Insilico Joins Hands With CDMO Bora in AI Drug Discovery Deal Worth $2.5B

Generative AI leader Insilico Medicine has added another major...

Research & Development

Market Access

Manufacturing

Replimune Cuts 224 Jobs in Massachusetts After Second FDA Rejection of RP1

Replimune is reducing its workforce by 224 employees across...
Manufacturing

Vivtex Expands R&D and Workforce Following $2.1 Billion Novo Nordisk Partnership

Despite securing a partnership valued at up to $2.1...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Commercial

Spero Shells Out Over $1B For Innovent’s Autoimmune Antibody

Spero Therapeutics is reshaping its strategy by shifting its...
Editorial Team -